Priapism secondary to prazosin overdose

Area of Science:

• Pharmacology
• Urology
• Cardiovascular Medicine

Background:

• Priapism is a recognized, albeit uncommon, adverse effect associated with specific antihypertensive medications.
• The European literature contains reports linking the antihypertensive agent prazosin to priapism.
• However, this association has not been documented in the American urologic literature.

Observation:

• This study reviews the existing literature regarding priapism as a complication of antihypertensive therapy.
• Particular attention is paid to the reported association between prazosin and priapism in European publications.
• The absence of similar reports in American urologic journals is noted.

Findings:

• A documented association exists between the antihypertensive drug prazosin and the development of priapism.
• This link has been established in European medical literature.
• There is a notable lack of reported cases or studies confirming this association in the American urologic context.

Implications:

• The findings suggest a potential underreporting or lack of awareness of prazosin-induced priapism in the American urologic community.
• Further research is warranted to investigate the prevalence and characteristics of priapism associated with prazosin in the United States.
• Clinicians should be aware of this potential adverse effect when prescribing prazosin for hypertension.